<DOC>
	<DOC>NCT00703391</DOC>
	<brief_summary>The purpose of this study is to assess the tolerability (effect of drug on body) and pharmacokinetics (effect of body on drug) of AZD9668 in patients with mild to moderate COPD</brief_summary>
	<brief_title>A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Mild to moderate COPD Smokers or exsmokers postmenopausal females Past history or current evidence of clinically significant heart disease Lung disease other than COPD Treatment with systemic steroids within 8 weeks of study visit 2 Treatment with antibiotics within 4 weeks of study visit 1 or study visit 2</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Chronic</keyword>
	<keyword>obstructive</keyword>
	<keyword>pulmonary</keyword>
	<keyword>lung</keyword>
	<keyword>respiratory disease</keyword>
	<keyword>tolerability</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>COPD</keyword>
</DOC>